KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Debt (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Total Debt for 17 consecutive years, with $5.7 billion as the latest value for Q4 2025.

  • Quarterly Total Debt fell 8.78% to $5.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Dec 2025, down 8.78% year-over-year, with the annual reading at $5.7 billion for FY2025, 8.78% down from the prior year.
  • Total Debt hit $5.7 billion in Q4 2025 for Quest Diagnostics, roughly flat from $5.7 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $6.3 billion in Q3 2024 to a low of $4.0 billion in Q1 2023.
  • Historically, Total Debt has averaged $4.7 billion across 5 years, with a median of $4.3 billion in 2023.
  • Biggest five-year swings in Total Debt: dropped 12.38% in 2021 and later soared 47.08% in 2024.
  • Year by year, Total Debt stood at $4.0 billion in 2021, then decreased by 0.8% to $4.0 billion in 2022, then increased by 18.42% to $4.7 billion in 2023, then skyrocketed by 31.91% to $6.2 billion in 2024, then dropped by 8.78% to $5.7 billion in 2025.
  • Business Quant data shows Total Debt for DGX at $5.7 billion in Q4 2025, $5.7 billion in Q3 2025, and $5.7 billion in Q2 2025.